230 related articles for article (PubMed ID: 8760304)
1. Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents.
Huang TS; Kuo ML; Shew JY; Chou YW; Yang WK
Oncogene; 1996 Aug; 13(3):625-32. PubMed ID: 8760304
[TBL] [Abstract][Full Text] [Related]
2. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
3. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
el-Deiry WS; Harper JW; O'Connor PM; Velculescu VE; Canman CE; Jackman J; Pietenpol JA; Burrell M; Hill DE; Wang Y
Cancer Res; 1994 Mar; 54(5):1169-74. PubMed ID: 8118801
[TBL] [Abstract][Full Text] [Related]
4. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
5. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
6. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
Tarunina M; Grimaldi M; Ruaro E; Pavlenko M; Schneider C; Jenkins JR
Oncogene; 1996 Aug; 13(3):589-98. PubMed ID: 8760300
[TBL] [Abstract][Full Text] [Related]
7. Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
Howard SP; Park SJ; Hughes-Davies L; Coleman CN; Price BD
Clin Cancer Res; 1996 Feb; 2(2):269-76. PubMed ID: 9816169
[TBL] [Abstract][Full Text] [Related]
8. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia.
Khanna KK; Beamish H; Yan J; Hobson K; Williams R; Dunn I; Lavin MF
Oncogene; 1995 Aug; 11(4):609-18. PubMed ID: 7651723
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
10. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated.
McKenzie PP; Guichard SM; Middlemas DS; Ashmun RA; Danks MK; Harris LC
Clin Cancer Res; 1999 Dec; 5(12):4199-207. PubMed ID: 10632361
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
[TBL] [Abstract][Full Text] [Related]
12. Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis.
Canman CE; Kastan MB
Oncogene; 1998 Feb; 16(8):957-66. PubMed ID: 9519869
[TBL] [Abstract][Full Text] [Related]
13. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
[TBL] [Abstract][Full Text] [Related]
14. Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1).
Yang F; von Knethen A; Brüne B
J Leukoc Biol; 2000 Dec; 68(6):916-22. PubMed ID: 11129661
[TBL] [Abstract][Full Text] [Related]
15. p53 protein accumulation in addition to the transactivation activity is required for p53-dependent cell cycle arrest after treatment of cells with camptothecin.
Jaks V; Jõers A; Kristjuhan A; Maimets T
Oncogene; 2001 Mar; 20(10):1212-9. PubMed ID: 11313865
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of RFT induces G1-S arrest and apoptosis via p53/p21(Waf1) pathway in glioma cell.
Kano H; Arakawa Y; Takahashi JA; Nozaki K; Kawabata Y; Takatsuka K; Kageyama R; Ueba T; Hashimoto N
Biochem Biophys Res Commun; 2004 May; 317(3):902-8. PubMed ID: 15081425
[TBL] [Abstract][Full Text] [Related]
17. Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis.
Katayose D; Wersto R; Cowan KH; Seth P
Cell Growth Differ; 1995 Oct; 6(10):1207-12. PubMed ID: 8845297
[TBL] [Abstract][Full Text] [Related]
18. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.
Zhang W; Grasso L; McClain CD; Gambel AM; Cha Y; Travali S; Deisseroth AB; Mercer WE
Cancer Res; 1995 Feb; 55(3):668-74. PubMed ID: 7834638
[TBL] [Abstract][Full Text] [Related]
19. Senescence-like changes induced by expression of p21(waf1/Cip1) in NIH3T3 cell line.
Chen X; Zhang W; Gao YF; Su XQ; Zhai ZH
Cell Res; 2002 Sep; 12(3-4):229-33. PubMed ID: 12296382
[TBL] [Abstract][Full Text] [Related]
20. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
